Comparison of Erector Spina Plan Block and Rhomboid Intercostal Block in Breast Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators compared ultrasound-guided erector spinae plane (ESP) block and rhomboid intercostal block (RIB) on postoperative analgesic effect in unilateral breast surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Rhomboid Intercostal Block vs Erector Spina Plan Block for Peri-operative Analgesia in Mastectomy

NCT04259502

Analgesia Perioperative Analgesia Postoperative Analgesia

UNKNOWN NA

Comparison of Bi-level Erector Spine Plane Block and Combined Pectoral I-II Block in Breast Surgery

NCT04689581

Postoperative Pain Analgesia

COMPLETED NA

Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block

NCT06407037

Erector Spinae Plane Block Serratus Posterior Superior Intercostal Plane Block Acute Pain +2 more

COMPLETED NA

ESPB and RIB for Pain Management Following Mastectomy Surgery

NCT04752150

Breast Cancer Breast Neoplasms Breast Cancer Female

COMPLETED NA

Erector Spinae Plane Block Versus Serratus Anterior Plane Block

NCT06862752

Post Operative Pain Opioid-Related Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study and potential risks, written consent was obtained from all patients.Patients who meet eligibility requirements will be randomized in a 1:1 ratio to erector spinae plane block and rhomboid intercostal block.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector Spinae Plane Block

Ultrasound(US)-guided erector spinae plan block(ESP) with 20 ml 0,25% bupivacaine at T4 vertebra level will performe preoperatively to all patients in the ESP group.

Group Type EXPERIMENTAL

Erector Spinae Plane Block

Intervention Type OTHER

Ultrasound(US)-guided erector spinae plan block(ESP) with 20 ml 0,25% bupivacaine at T4 vertebra level will performe preoperatively to all patients in the ESP group.

Rhomboid Intercostal Block

Ultrasound(US)-guided rhomboid intercostal block(RIB) with 20 ml 0,25% bupivacaine at T5-T6 vertebra level will performe preoperatively to all patients in the RIB group.

Group Type EXPERIMENTAL

Rhomboid Intercostal Block

Intervention Type OTHER

Ultrasound(US)-guided rhomboid intercostal block(RIB) with 20 ml 0,25% bupivacaine at T5-T6 vertebra level will performe preoperatively to all patients in the RIB group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector Spinae Plane Block

Ultrasound(US)-guided erector spinae plan block(ESP) with 20 ml 0,25% bupivacaine at T4 vertebra level will performe preoperatively to all patients in the ESP group.

Intervention Type OTHER

Rhomboid Intercostal Block

Ultrasound(US)-guided rhomboid intercostal block(RIB) with 20 ml 0,25% bupivacaine at T5-T6 vertebra level will performe preoperatively to all patients in the RIB group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who will undergo unilateral breast-conserving surgery (BCS) or modified radical mastectomy (MRM) with or without axillary lymph node dissection
* Patients undergoing elective surgery
* ASA (American Society of Anesthesiologists) physical status classification I-III

Exclusion Criteria

* Use of anticoagulants
* Allergy to the medications to be used
* Patients who use analgesic drugs due to a history of chronic pain
* ASA (American Society of Anesthesiologists) physical status classification IV-V
* Patients with psychiatric disorders
* Presence of infection in the area where the block will be applied
* Presence of deformity in the patient's spinal, paraspinal and area where the block will be applied
* The patient does not accept the block application or cannot cooperate with the patient

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No